Gritstone Oncology, Inc

(NASDAQ:GRTS)

Latest On Gritstone Oncology, Inc (GRTS):

Date/Time Type Description Signal Details
2023-05-13 00:16 ESTNewsGritstone stock falls ~10% after Q1 net loss widens, revenues shrinkN/A
2023-05-12 10:01 ESTNewsGritstone bio, Inc. (GRTS) Q1 2023 Earnings Call TranscriptN/A
2023-05-11 20:27 ESTNewsGritstone bio GAAP EPS of -$0.30 beats by $0.04, revenue of $2.44M misses by $0.73MN/A
2023-05-11 05:24 ESTNewsGritstone bio Q1 2023 Earnings PreviewN/A
2023-04-23 06:26 ESTNewsGritstone bio: Q4 2023 Data Readout Is Going To Be Major Inflection PointN/A
2023-03-28 22:37 ESTNewsGritstone bio draws Buy rating at B. Riley on mRNA potentialN/A
2023-03-21 05:23 ESTNewsA Peek At Gritstone bio's PipelineN/A
2023-03-11 00:00 ESTNewsGritstone bio, Inc. (GRTS) Q4 2022 Earnings Call TranscriptN/A
2023-03-11 00:00 ESTNewsGritstone bio closes down 8%; has small cash position, loan agreement with SVB FinancialN/A
2023-03-10 08:54 ESTNewsGritstone bio Inc. (GRTS) Q4 2022 Results - Earnings Call TranscriptN/A
2023-03-09 17:25 ESTNewsGritstone Oncology GAAP EPS of -$1.32 beats by $0.10, revenue of $19.95M beats by $1.36MN/A
2023-01-20 18:29 ESTNewsGritstone bio (GRTS) Presents at the 41st Annual J.P. Morgan Healthcare Conference - SlideshowN/A
2023-01-02 13:14 ESTNewsGritstone bio: Keep An Eye On This Discounted Cancer Vaccine Developer In 2023N/A
2022-12-14 00:18 ESTNewsGritstone bio rallies after U.S. patent win for mRNA-based vaccine techN/A
2022-11-04 03:22 ESTNewsGritstone Oncology GAAP EPS of -$0.35, revenue of $3.02MN/A
2022-10-31 18:56 ESTNewsGritstone bio adds 14% after bullish view from Piper SandlerN/A
2022-10-25 11:58 ESTNewsGritstone bio to sell 6.6M shares for gross proceeds of ~$45MN/A
2022-10-25 11:58 ESTNewsGritstone self-amplifying mRNA COVID vaccine shows promise in 2 early stage trialsN/A
2022-09-26 20:27 ESTNewsGritstone bio: Early Data For SLATE Candidate Sets Up 2023 CatalystN/A
2022-09-17 04:20 ESTNewsGritstone bio (GRTS) Presents at ESMO Congress 2022N/A
2022-09-12 18:39 ESTNewsGritstone vaccine-based immunotherapies show promise versus solid tumors in trialN/A
2022-08-23 03:57 ESTNewsGritstone bio sheds 14% as Goldman Sachs cuts to sell on liquidity issuesN/A
2022-08-17 02:17 ESTNewsGritstone reaches six-month high on publication of data for cancer vaccineN/A
2022-08-07 01:43 ESTNewsGritstone bio Inc. (GRTS) CEO Andrew Allen on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-05 03:29 ESTNewsGritstone Oncology GAAP EPS of -$0.34 beats by $0.07, revenue of $5.47M beats by $2.28MN/A
2022-08-03 21:25 ESTNewsGritstone Oncology Q2 2022 Earnings PreviewN/A
2022-07-21 17:10 ESTNewsGritstone bio announces $80M credit facilityN/A
2022-07-06 06:22 ESTNewsGritstone bio: Potential To Advance Colorectal Cancer TreatmentN/A
2022-06-14 17:17 ESTNewsGritstone bio: Investing In A Premium mRNA Technology At A Discounted ValuationN/A
2022-05-06 03:32 ESTNewsGritstone Oncology GAAP EPS of -$0.34 beats by $0.02, revenue of $7.19M beats by $2.98MN/A
2022-03-11 12:00 ESTNewsGritstone Oncology GAAP EPS of -$0.95, revenue of $48.21MN/A
2022-03-11 12:00 ESTNewsGritstone bio files for $250M mixed shelf offeringN/A
2022-01-18 06:02 ESTNewsGritstone: Why The Stock Fell On Positive DataN/A
2022-01-15 00:39 ESTNewsGritstone bio (GRTS) Investor Presentation (Slideshow)N/A
2022-01-13 15:56 ESTNewsGritstone begins phase 2/3 colorectal cancer trial dosing; positive data in early studyN/A
2022-01-04 13:36 ESTNewsGritstone reports positive results from first cohort of Phase 1 CORAL-BOOST study in COVID-19N/A
2021-12-13 20:45 ESTNewsGritstone Bio added to the Nasdaq Biotech IndexN/A
2021-12-13 20:44 ESTNewsGritstone announces inducement grants under Nasdaq listing ruleN/A
2021-12-06 16:26 ESTNewsGritstone to receive additional funding from CEPI for Omicron vaccine studiesN/A
2021-12-01 02:25 ESTNewsGritstone extends rally after dismissing impact of Omicron on its COVID-19 vaccinesN/A
2021-11-23 23:12 ESTNewsGritstone bio (GRTS) Investor Presentation - SlideshowN/A
2021-11-23 23:11 ESTNewsGritstone announces inducement grantsN/A
2021-11-10 09:06 ESTNewsGritstone shares rise after preclinical data from next-generation COVID-19 vaccine studyN/A
2021-11-08 12:43 ESTNewsGritstone Poised To Dominate mRNA MarketN/A
2021-11-04 10:04 ESTNewsGritstone Oncology EPS beats by $0.11, beats on revenueN/A
2021-09-25 03:39 ESTNewsGritstone Oncology (GRTS) ESMO 2021Virtual Congress Presentation - SlideshowN/A
2021-09-21 19:48 ESTNewsGritstone bio raises $55M through private placement financingN/A
2021-09-21 19:48 ESTNewsABCL, TCRR, KYMR and GRTS among after hours moversN/A
2021-09-21 19:47 ESTNewsDosing underway in Gritstone's Phase 2 SLATE v2 trial in patients with solid tumorsN/A
2021-09-21 19:45 ESTNewsGritstone gets dosing underway in COVID-19 vaccine booster and immunogenicity enhancer trialN/A

About Gritstone Oncology, Inc (GRTS):

Gritstone Oncology, Inc., a clinical-stage biotechnology company, engages in developing tumor-specific cancer immunotherapies to fight various cancer types and infectious diseases. Its lead product candidate is GRANITE, which is in Phase I/II clinical trial for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder and microsatellite stable, and colorectal cancers. The company is also developing SLATE, an off-the-shelf immunotherapy candidate for the treatment of common solid tumors, including metastatic non-small cell lung cancer, colorectal cancer, pancreatic cancer, and other mutation-positive tumors. Gritstone Oncology, Inc. has a strategic collaboration with bluebird bio, Inc. The company was founded in 2015 and is headquartered in Emeryville, California.

GRTS Quotes by TradingView

See Advanced Chart

General

  • Name Gritstone Oncology, Inc
  • Symbol GRTS
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 169
  • Fiscal Year EndDecember
  • IPO Date2018-09-28
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://gritstoneoncology.com
View More

Valuation

  • Trailing PE 0.6
  • Price/Sales (Trailing 12 Mt.) 162.85
  • Price/Book (Most Recent Quarter) 10.71
  • Enterprise Value Revenue 203.33
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$2.13
  • Next Year EPS Estimate -$2.11
  • Next Quarter EPS Estimate -$0.46
  • Operating Margin -2626%
  • Return on Assets -33%
  • Return on Equity -70%
  • Revenue 4.04 million
  • Earnings Per Share -$3.21
  • Revenue Per Share $0.11
  • Gross Profit -84606000
  • Quarterly Earnings Growth 52.6%
View More

Highlights

  • Market Capitalization 680.92 million
  • EBITDA -73576000
  • PE Ratio -0.42
  • Analyst Target Price $25.33
  • Book Value Per Share $3.51
View More

Share Statistics

  • Shares Outstanding 48.95 million
  • Shares Float 30.33 million
  • % Held by Insiders 902%
  • % Held by Institutions 65.43%
  • Shares Short 3.07 million
  • Shares Short Prior Month 2.84 million
  • Short Ratio 2.13
  • Short % of Float 9%
  • Short % of Shares Outstanding 6%
View More

Technicals

  • Beta 0.32
  • 52 Week High $28.52
  • 52 Week Low $2.54
  • 50 Day Moving Average 15.02
  • 200 Day Moving Average 7.19
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Gritstone Oncology, Inc (GRTS) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Gritstone Oncology, Inc (GRTS) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-11$1.35 million-$0.69-$0.61-13.11%
2020-09-302020-11-05$N/A-$0.69-$0.62-11.89%
2020-06-302020-08-05$N/A-$0.69-$0.769.21%
2020-03-312020-05-07$N/A-$0.71-$0.721.93%
2019-12-312020-03-11$884000-$0.77-$0.72-6.46%
2019-09-302019-11-12$984000-$0.77-$0.65-19.07%
2019-06-302019-08-12$1.15 million-$0.63-$0.59-6.78%
2019-03-312019-05-13$1.35 million-$0.62-$0.654.13%
2018-12-312019-03-28$1.09 million-$0.61-$0.632.56%
2018-09-302018-11-14$96000-$0.84-$0.57-46.52%

Gritstone Oncology, Inc (GRTS) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Gritstone Oncology, Inc (GRTS) Chart:

Gritstone Oncology, Inc (GRTS) News:

Below you will find a list of latest news for Gritstone Oncology, Inc (GRTS) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Gritstone Oncology, Inc (GRTS) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-05-160.50.03CALL0 1923617.37FALSE00
2025-05-1610CALL0 2540FALSE00
2025-05-161.50CALL0 510FALSE00
2025-05-1620CALL0 00FALSE00
2025-05-162.50CALL0 70FALSE00
2025-05-1650CALL0 00FALSE00
2025-05-167.50CALL0 60FALSE00
2025-05-160.50.5PUT0 160TRUE00
2025-05-1611PUT0 600TRUE00
2025-05-161.51.5PUT0 690TRUE00
2025-05-1622PUT0 640TRUE00
2025-05-162.52.5PUT0 600TRUE00
2025-05-1655PUT0 570TRUE00
2025-05-167.57.5PUT0 00TRUE00

Latest GRTS Trades:

Date Shares Price
Jun 13, 2022 7:57 PM EST100$2.09
Jun 13, 2022 7:57 PM EST500$2.09
Jun 13, 2022 7:57 PM EST403$2.09
Jun 13, 2022 7:58 PM EST22$2.09
Jun 13, 2022 7:59 PM EST100$2.085

Gritstone Oncology, Inc (GRTS) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1656634/000156761920012490/0001567619-20-012490-index.htm
2019-02-19UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1656634/000000000019002625/0000000000-19-002625-index.htm
2019-10-28UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1656634/000000000019014909/0000000000-19-014909-index.htm
2019-02-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1656634/000031506619001075/0000315066-19-001075-index.htm
2019-05-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1656634/000031506619001522/0000315066-19-001522-index.htm
2020-02-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1656634/000031506620000951/0000315066-20-000951-index.htm
2020-08-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1656634/000031506620001681/0000315066-20-001681-index.htm
2020-02-07SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1656634/000083423720008072/0000834237-20-008072-index.htm
2019-11-21SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1656634/000091957419007401/0000919574-19-007401-index.htm
2020-02-06SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1656634/000091957420000801/0000919574-20-000801-index.htm
2018-12-28DRSDraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1656634/000095012318012543/0000950123-18-012543-index.htm
2018-10-12SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1656634/000107261318000508/0001072613-18-000508-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1656634/000110465919008635/0001104659-19-008635-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1656634/000110465920021819/0001104659-20-021819-index.htm
2020-04-24DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1656634/000114036120009728/0001140361-20-009728-index.htm
2020-04-24DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1656634/000114036120009732/0001140361-20-009732-index.htm
2018-09-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1656634/000114420418051311/0001144204-18-051311-index.htm
2018-10-03SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1656634/000114420418052347/0001144204-18-052347-index.htm
2018-10-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1656634/000114420418052384/0001144204-18-052384-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1656634/000114420419008071/0001144204-19-008071-index.htm
2018-09-27S-1MEFRegistration adding securities to prior Form S-1 registration [Rule 462(b)]https://www.sec.gov/Archives/edgar/data/1656634/000119312518285976/0001193125-18-285976-index.htm
2018-10-01424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1656634/000119312518288170/0001193125-18-288170-index.htm
2018-10-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1656634/000119312518290860/0001193125-18-290860-index.htm
2018-10-02S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1656634/000119312518290941/0001193125-18-290941-index.htm
2018-11-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1656634/000119312518325800/0001193125-18-325800-index.htm
2019-01-11SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1656634/000119312519006214/0001193125-19-006214-index.htm
2019-02-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1656634/000119312519028323/0001193125-19-028323-index.htm
2019-02-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1656634/000119312519038151/0001193125-19-038151-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1656634/000119312519040433/0001193125-19-040433-index.htm
2019-03-28S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1656634/000119312519090602/0001193125-19-090602-index.htm
2019-04-1910-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1656634/000119312519111139/0001193125-19-111139-index.htm
2019-04-22S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1656634/000119312519113421/0001193125-19-113421-index.htm
2019-04-22CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1656634/000119312519113487/0001193125-19-113487-index.htm
2019-04-22CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1656634/000119312519113498/0001193125-19-113498-index.htm
2019-04-25424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1656634/000119312519119628/0001193125-19-119628-index.htm
2019-04-26DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1656634/000119312519122379/0001193125-19-122379-index.htm
2019-04-26DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1656634/000119312519122408/0001193125-19-122408-index.htm
2019-06-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1656634/000119312519179025/0001193125-19-179025-index.htm
2019-09-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1656634/000119312519244976/0001193125-19-244976-index.htm
2019-10-15S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1656634/000119312519267723/0001193125-19-267723-index.htm
2019-11-05S-3/ARegistration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1656634/000119312519284144/0001193125-19-284144-index.htm
2019-11-05CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1656634/000119312519284152/0001193125-19-284152-index.htm
2019-11-06CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1656634/000119312519285867/0001193125-19-285867-index.htm
2019-11-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1656634/000119312519287280/0001193125-19-287280-index.htm
2019-11-15424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1656634/000119312519293472/0001193125-19-293472-index.htm
2019-12-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1656634/000119312519314015/0001193125-19-314015-index.htm
2020-01-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1656634/000119312520005810/0001193125-20-005810-index.htm
2020-03-11S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1656634/000119312520070403/0001193125-20-070403-index.htm
2020-05-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1656634/000119312520130954/0001193125-20-130954-index.htm
2020-06-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1656634/000119312520174058/0001193125-20-174058-index.htm
2020-07-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1656634/000119312520191868/0001193125-20-191868-index.htm
2020-10-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1656634/000119312520275481/0001193125-20-275481-index.htm
2019-03-2810-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1656634/000156459019009825/0001564590-19-009825-index.htm
2019-05-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1656634/000156459019018685/0001564590-19-018685-index.htm
2019-08-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1656634/000156459019031362/0001564590-19-031362-index.htm
2019-11-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1656634/000156459019042681/0001564590-19-042681-index.htm
2020-03-1110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1656634/000156459020009886/0001564590-20-009886-index.htm
2020-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1656634/000156459020022416/0001564590-20-022416-index.htm
2020-08-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1656634/000156459020036449/0001564590-20-036449-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1656634/000156459020050916/0001564590-20-050916-index.htm
2018-09-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1656634/000156761918003226/0001567619-18-003226-index.htm
2018-09-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1656634/000156761918003228/0001567619-18-003228-index.htm
2018-09-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1656634/000156761918003229/0001567619-18-003229-index.htm
2018-09-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1656634/000156761918003230/0001567619-18-003230-index.htm
2018-09-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1656634/000156761918003232/0001567619-18-003232-index.htm
2018-09-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1656634/000156761918003234/0001567619-18-003234-index.htm
2018-09-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1656634/000156761918003235/0001567619-18-003235-index.htm
2018-09-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1656634/000156761918003236/0001567619-18-003236-index.htm
2018-09-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1656634/000156761918003237/0001567619-18-003237-index.htm
2018-09-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1656634/000156761918003238/0001567619-18-003238-index.htm
2018-09-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1656634/000156761918003240/0001567619-18-003240-index.htm
2018-09-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1656634/000156761918003242/0001567619-18-003242-index.htm
2018-09-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1656634/000156761918003243/0001567619-18-003243-index.htm
2018-09-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1656634/000156761918003244/0001567619-18-003244-index.htm
2018-09-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1656634/000156761918003245/0001567619-18-003245-index.htm
2018-09-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1656634/000156761918003246/0001567619-18-003246-index.htm
2018-09-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1656634/000156761918003252/0001567619-18-003252-index.htm
2018-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1656634/000156761918003533/0001567619-18-003533-index.htm
2018-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1656634/000156761918003534/0001567619-18-003534-index.htm
2018-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1656634/000156761918003535/0001567619-18-003535-index.htm
2018-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1656634/000156761918003536/0001567619-18-003536-index.htm
2018-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1656634/000156761918003538/0001567619-18-003538-index.htm
2018-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1656634/000156761918003541/0001567619-18-003541-index.htm
2019-03-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1656634/000156761919006344/0001567619-19-006344-index.htm
2019-03-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1656634/000156761919006914/0001567619-19-006914-index.htm
2019-03-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1656634/000156761919006915/0001567619-19-006915-index.htm
2019-03-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1656634/000156761919006916/0001567619-19-006916-index.htm
2019-03-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1656634/000156761919006917/0001567619-19-006917-index.htm
2019-03-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1656634/000156761919006918/0001567619-19-006918-index.htm
2019-03-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1656634/000156761919006919/0001567619-19-006919-index.htm
2019-03-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1656634/000156761919006920/0001567619-19-006920-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1656634/000156761919013755/0001567619-19-013755-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1656634/000156761919013756/0001567619-19-013756-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1656634/000156761919013757/0001567619-19-013757-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1656634/000156761919013760/0001567619-19-013760-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1656634/000156761919013762/0001567619-19-013762-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1656634/000156761919013764/0001567619-19-013764-index.htm
2019-07-293Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1656634/000156761919015361/0001567619-19-015361-index.htm
2019-07-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1656634/000156761919015362/0001567619-19-015362-index.htm
2019-08-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1656634/000156761919017520/0001567619-19-017520-index.htm
2019-09-133Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1656634/000156761919018264/0001567619-19-018264-index.htm
2019-09-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1656634/000156761919018265/0001567619-19-018265-index.htm
2020-02-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1656634/000156761920005025/0001567619-20-005025-index.htm
2020-02-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1656634/000156761920005027/0001567619-20-005027-index.htm
2020-02-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1656634/000156761920005030/0001567619-20-005030-index.htm
2020-02-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1656634/000156761920005032/0001567619-20-005032-index.htm
2020-02-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1656634/000156761920005034/0001567619-20-005034-index.htm
2020-02-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1656634/000156761920005036/0001567619-20-005036-index.htm
2020-02-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1656634/000156761920005038/0001567619-20-005038-index.htm
2020-02-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1656634/000156761920005040/0001567619-20-005040-index.htm
2020-04-143Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1656634/000156761920007936/0001567619-20-007936-index.htm
2020-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1656634/000156761920010601/0001567619-20-010601-index.htm
2020-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1656634/000156761920012485/0001567619-20-012485-index.htm
2020-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1656634/000156761920012486/0001567619-20-012486-index.htm
2020-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1656634/000156761920012487/0001567619-20-012487-index.htm
2020-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1656634/000156761920012488/0001567619-20-012488-index.htm
2020-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1656634/000156761920012489/0001567619-20-012489-index.htm
2020-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1656634/000156761920012490/0001567619-20-012490-index.htm
2020-08-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1656634/000156761920015776/0001567619-20-015776-index.htm
2018-09-27EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1656634/999999999518002480/9999999995-18-002480-index.htm
2019-04-24EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1656634/999999999519000819/9999999995-19-000819-index.htm
2019-11-08EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1656634/999999999519002541/9999999995-19-002541-index.htm
2018-10-01CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1656634/999999999718008202/9999999997-18-008202-index.htm

Gritstone Oncology, Inc (GRTS) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Gritstone Oncology, Inc (GRTS). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 902%
Institutional Ownership: 6543%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-08-21Raphael RousseauOfficerSell10,000.0010.76107,631.000.00https://www.sec.gov/Archives/edgar/data/1656634/000156761919017520/0001567619-19-017520-index.htm
2019-01-29Erin JonesOfficerBuy10,000.000.353,450.0010,000.00https://www.sec.gov/Archives/edgar/data/1656634/000156761919006344/0001567619-19-006344-index.htm
2019-08-21Raphael RousseauOfficerBuy10,000.000.767,600.0010,000.00https://www.sec.gov/Archives/edgar/data/1656634/000156761919017520/0001567619-19-017520-index.htm
2020-08-17Erin JonesOfficerBuy10,000.000.353,450.0020,000.00https://www.sec.gov/Archives/edgar/data/1656634/000156761920015776/0001567619-20-015776-index.htm
2018-09-28Clarus Lifesciences III, L.P.10% Share HolderBuy333,333.0015.004,999,995.00333,333.00https://www.sec.gov/Archives/edgar/data/1656634/000156761918003533/0001567619-18-003533-index.htm
2018-09-28Nicholas SimonDirectorBuy333,333.0015.004,999,995.00333,333.00https://www.sec.gov/Archives/edgar/data/1656634/000156761918003534/0001567619-18-003534-index.htm